Manufacturing and Production

Showing 15 posts of 5863 posts found.

Pfizer resolves pension dispute at Irish facility

April 5, 2017 Manufacturing and Production, Research and Development Ireland, Pfizer, Siptu

Pfizer and trade union Siptu have reached an agreement over a pension dispute at the company’s plant at Ringaskiddy in …
gsk_wall

GSK hit by recall of 600,000 inhalers

April 5, 2017 Manufacturing and Production, Research and Development FDA, GSK, Ventolin

The FDA has released that GSK would be voluntarily recalling close to 600,000 of its Ventolin asthma inhalers across the …
joanne_estell

Joanne Estell joins Shield Therapeutics as CFO

April 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Shield Therapeutics has announced that it has recruited Joanne Estell as its new CFO and board member; she will step …
shire_image_4

NICE turns down Shire’s pancreatic cancer treatment

April 4, 2017 Manufacturing and Production, Sales and Marketing NICE, Pancreatic cancer, Shire

NICE has announced its intention not to recommend the NHS use of Shire’s Onivyde (pegylated liposomal irinotecan) for the treatment …
hero-plus

Mylan hit with fresh lawsuit over EpiPen pricing

April 4, 2017 Manufacturing and Production, Sales and Marketing Mylan, epipen, pricing

Just as it faces worldwide reports that over 80,000 of its EpiPens do not function properly and as the FDA …
teva_copy

Teva’s Huntington’s treatment becomes first FDA-approved deuterated drug

April 4, 2017 Manufacturing and Production, Sales and Marketing Austedo, FDA, Teva

Israel’s Teva Pharmaceuticals has announced that the FDA has given its approval for Austedo (deutetrabenazine) in the treatment of chorea …
shutterstock_254160583

Sanofi to pay $20m fine for overcharging US veterans

April 4, 2017 Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US

Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …
european_commission

Novartis combo expands into lung cancer with EU approval

April 4, 2017 Manufacturing and Production, Sales and Marketing NSCLC, Novartis, Tafinlar, mekinist

Novartis has announced that its Tafinlar (dabrafenib) and Mekinist (trametinib) drug combo has been approved by the European Commission (EC) …
robert_ring

Vencerx Therapeutics ring the changes appointing ex-Pfizer Director as CEO

April 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Vencerx therapeutics

Vencerx Therapeutics, a biotech focused on developing treatments for neurodevelopmental disorders, has announced the appointment of Robert Ring as CEO. …
rare_disease_day_logo

Behind Rare Disease Day 2017

April 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Rare Disease Day, rare disease

Rare Disease Day falls on the last day of February, meaning every four years it occurs on a leap year, …

Crunch Time: The Impact of Serialisation Requirements on Packaging Operations

March 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI services

Introduction More than three years have passed since the US federal government signed the Drug Supply Chain Security Act (DSCSA) …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s the end of the week, and the headlines were populated with stand-out stories that proved popular with our readers. …
giles_platford

Takeda names new President of Europe and Canada Business Unit

March 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

Takeda has named Giles Platford as its new President of Europe and Canada (EUCAN) Business Unit as of 1 April, …
paul-catchpole

Insider Interview: ABPI’s Paul Catchpole discusses NICE’s new fast-track appraisal system

March 30, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Insider Interview, NICE, Paul Catchpole, fast track

Paul Catchpole, Value and Access Director at the Association of the British Pharmaceutical Industry (ABPI), gives his thoughts on the …
pharmafocus_april_front_cover

The April 2017 edition of Pharmafocus is available to read online now!

March 29, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, Pharmafocus new issue

From industry reaction to NICE’s new regulatory guidelines to the rising threat of counterfeit medicine, you can read all the …
The Gateway to Local Adoption Series

Latest content